Elad Jacoby

Prof. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby has authored over 240 scientific publications on advanced cellular medicine.

Specialization & Focus

Prof. Jacoby specializes in treating high-risk pediatric leukemias and lymphomas. He focuses on patients who have limited standard treatment options. The doctor integrates CAR T–cell therapy with bone marrow transplantation for complex spinal reconstruction and high-risk cases. He also uses precision medicine and immunotherapy to create individualized care plans.

His clinical expertise includes:

• CAR T–cell therapy — a treatment that reprograms the immune system to fight cancer
• Allogenic and autologous bone marrow and stem cell transplantation
• Treatment of acute lymphoblastic leukemia (ALL) and aggressive lymphomas
• Mitochondrial Augmentation Therapy for rare conditions
• Advanced cellular immunotherapy including anti-viral T-cell therapies for immunocompromised patients

Achievements & Leadership

The specialist led one of the first national programs for pediatric leukemia. He is the Medical Director of the Advanced Biotherapy Center. Dr. Jacoby is an Associate Professor at Tel Aviv University. Additionally, he serves on the IBFM CAR T–Cell Taskforce to improve global treatment standards.

Work Experience

• Head, Pediatric Cell Therapy Center, Sheba Medical Center
• Medical Director, Advanced Biotherapy Center, Sheba Medical Center
• Associate Professor, Tel Aviv University School of Medicine
• Member, Institutional Review Board, Sheba Medical Center

Education & Training

• Medical Degree – Tel Aviv University School of Medicine
• Pediatrics Residency – Sheba Medical Center
• Fellowship in Pediatric Hematology & Oncology – Johns Hopkins Hospital, USA
• Clinical & Research Fellowship – National Cancer Institute (NCI), USA

Research & Publications

Prof. Jacoby leads international clinical trials for next-generation cancer therapies. He collaborates with Johns Hopkins Hospital and the National Cancer Institute. His research focuses on immune system modulation and mitochondrial medicine. Furthermore, he has contributed to over 240 published peer-reviewed studies.

Professional Memberships & Certifications

• Board-certified in Pediatrics
• Board-certified in Pediatric Hematology and Oncology
• Member, IBFM CAR T–Cell Taskforce